Gilead Sciences, Inc.
GILD· Nasdaq
GILDGilead Sciences, Inc.
Source filing unavailable
| Metric | Q1 2011 | Q1 2010 | Q1 2009 |
|---|---|---|---|
| Revenue | $1.93B | $2.09B | $1.53B |
| Net Income | $651.14M | $854.90M | $589.11M |
| EPS Diluted | $0.40 | $0.92 | $0.63 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Gilead Sciences, Inc. · CIK 882095 · Engraved from SEC EDGAR
